Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · Real-Time Price · USD
20.64
+1.22 (6.28%)
At close: Nov 6, 2026, 4:00 PM EST
20.64
0.00 (0.00%)
Pre-market: Nov 9, 2026, 4:55 AM EST

Tectonic Therapeutic Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, Tectonic Therapeutic stock has a consensus rating of "Strong Buy" and an average price target of $71. The average 1-year stock price forecast is 243.99% higher than the current stock price, while the lowest is $26 (+25.97%) and the highest is $93 (+350.58%).

Price Target: $71 (+243.99%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$26$71$76$93
Change+25.97%+243.99%+268.22%+350.58%

Analyst Ratings

The average analyst rating for Tectonic Therapeutic stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingMay '26Jun '26Jul '26Aug '26Sep '26Oct '26
Strong Buy999988
Buy111111
Hold000001
Sell000000
Strong Sell000000
Total10101010910

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
Oppenheimer
No rating
Oppenheimer
Buy
Maintains
$80
BuyMaintains$80+287.60%Nov 6, 2026
Stifel Nicolaus
Stifel Nicolaus
Buy
Maintains
$75
BuyMaintains$75+263.37%Nov 6, 2026
Piper Sandler
Piper Sandler
Buy
Maintains
$76
BuyMaintains$76+268.22%Nov 6, 2026
Leerink Partners
Leerink Partners
Buy
Reiterates
$60
BuyReiterates$60+190.70%Oct 16, 2026
UBS
UBS
Hold
Initiates
$26
HoldInitiates$26+25.97%Oct 11, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-5.77
EPS Next Year
-4.76
from -5.77
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
------
Operating Income
-15.61M-32.83M-44.65M-58.02M-84.04M-109.49M
Net Income
-8.93M-32.18M-42.82M-57.98M-74.15M-102.64M
EPS
------5.77
Free Cash Flow
-----60.29M-87.00M
No. Analysts
-----8
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
Highn/a
Avgn/a
Lown/a

Revenue Growth

Revenue Growth20272028
High-
Avg-
Low-

EPS Forecast

EPS202620272028
High-5.77
Avg-5.77
Low-5.77

EPS Growth

EPS Growth20272028
High-
Avg-
Low-